The FDA has finalized guidance on using electronic health record (EHR) data in clinical trials.
With a nationwide push toward incorporating real-world evidence in decision making, the FDA has finalized guidance on using electronic health record (EHR) data in clinical trials.
The guidance is intended to assist sponsors, clinical investigators, and other stakeholders in using the data for clinical investigations.
“In an effort to modernize and streamline clinical investigations, the goals of the guidance are to facilitate the use of EHR data in clinical investigations and to promote the interoperability of EHR and electronic data capture (EDC) systems,” stated the document.
The final guidance comes 2 years after the FDA announced the availability of the draft guidance. The guidance provides recommendations and best practices for:
Based on feedback during the comment period, the final guidance includes clarifications for:
Access to real-world data has the potential to support the approval of new indications for already approved drugs, as well as other regulatory decisions based on clinical investigations. During the 2018 American Society of Clinical Oncology Annual Meeting, June 1-5, in Chicago, Illinois, a session discussed the growing role of real-world evidence and how it can be leveraged in combination with clinical trials to inform evidence-based care.
Panelists highlighted some gaps in clinical trials that real-world evidence can fill. They noted that trials are not the optimal fit for questions of application of the innovation to broad and diverse populations and they are not well suited to answer post-hoc questions about differences in efficacy among subgroups or application to populations outside the clinical trials, often due to a small and/or homogenous sample size.
Real-world evidence can address those gaps by providing robust and well-rounded data, they argued.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More